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Abstract The study aims to determine the expression of
telomerase reverse transcriptase (TERT) in the glial scar fol-
lowing spinal cord injury in the rat, and to explore its rela-
tionship with glial scar formation. A total of 120 Sprague–
Dawley rats were randomly divided into three groups: SCI
only group (without TERT interference), TERT siRNA group
(with TERT interference), and sham group. The TERT siRNA
and SCI only groups received spinal cord injury induced by
the modified Allen’s weight drop method. In the sham group,
the vertebral plate was opened to expose the spinal cord, but no
injury was modeled. Five rats from each group were sacrificed
under anesthesia at days 1, 3, 5, 7, 14, 28, 42, and 56 after
spinal cord injury. Specimens were removed for observation
of glial scar formation using hematoxylin-eosin staining and
immunofluorescence detection. mRNA and protein expres-
sions of TERT and glial fibrillary acidic protein (GFAP) were
detected by reverse-transcription (RT)-PCR and western
blotting, respectively. Hematoxylin-eosin staining showed
evidence of gliosis and glial scarring in the spinal cord injury
zone of the TERT siRNA and SCI only groups, but not in the
sham group. Immunofluorescence detection showed a sig-
nificant increase in GFAP expression at all time points after
spinal cord injury in the SCI only group (81 %) compared with
the TERT siRNA group (67 %) and sham group (2 %). In
contrast, the expression of neurofilament protein 200 (NF-
200) was gradually reduced and remained at a stable level until
28 days in the SCI only group. There were no NF-200-labeled
cells in the spinal cord glial scar and cavity at day 56 after
spinal cord injury. NF-200 expression at each time point was
significantly lower in the SCI only group than the TERT
siRNA group, while there was no change in the sham group.
Western blotting showed that TERT and GFAP protein
expressions changed dynamically and showed a linear rela-
tionship in the SCI only group (r = 0.765, P \ 0.01), while
there was no obvious linear relationship in the sham group
(r = 0.208, P = 0.121). RT-PCR results showed a dynamic
expression of TERT and GFAP mRNA in the SCI only group,
exhibiting a linear relationship (r = 0.722, P \ 0.01), while
there was no linear relationship in the sham group (r = 0.206,
P = 0.180). Our data indicate that TERT has a dynamic
expression in the spinal cord glial scar, which positively cor-
relates to GFAP expression, and may be important for pro-
moting glial scar formation.
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Introduction
Spinal cord injury can induce a series of severe motor,
sensory, and autonomic dysfunctions in humans. Formation
and development of glial scarring is the predominant
pathological change following spinal cord injury [1].
Experimental studies have shown that various interventions
for spinal cord injury are unable to penetrate the glial scar
barrier to prevent glial scar formation. Astrocytes play a
critical role in glial scar formation and inhibition of axonal
regeneration [2, 3].
After spinal cord injury, astrocytes become activated and
show reactive hyperplasia, hypertrophy and proliferation,
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and increased glial fibrillary acidic protein (GFAP) expres-
sion and cell division [4, 5].
In addition to protecting the telomere, telomerase
reverse transcriptase (TERT) has multiple non-telomere
length-dependent effects that are closely associated with
cell activation, proliferation, and apoptosis [6–9]. Some
researchers reported that excitatory and traumatic brain
injury could induce telomerase expression in microglia by
activating a series of cytokines and growth factors, thereby
promoting glial scar formation [10]. However, the role of
TERT in the activation and proliferation of astrocytes after
spinal cord injury, and glial scar formation and develop-
ment remains unclear. Thus, in the present study we
examined the effects of TERT on glial scar formation after
spinal cord injury in rats.
Materials and Methods
Main Reagents and Instruments
The reverse transcription (RT)-PCR TERT assay kit was
purchased from Roche (St. Louis, MO, USA). The GFAP
detection kit, FITC-conjugated goat anti-rabbit antibody,
mouse anti-GFAP antibody, rabbit anti-GFAP antibody,
and neurofilament protein 200 (NF-200) were purchased
from Sigma. The plasmid vector PBCA-NPS-TERT was
provided by Invitrogen (Carlsbad, CA, USA). The PCR
instrument was from BioRad Inc. (Berkeley, CA USA).
Spinal Cord Injury Model
A total of 120 male Sprague–Dawley rats (clean grade,
180–220 g) were purchased from the Experimental Animal
Center, Xinjiang Medical University (license No. SYXK
(Xin) 2003-001). The rats were randomized into SCI only
group, TERT siRNA group, and sham group (n = 40 rats
per group). All rats were anesthetized with a combination
of 2 mL ketamine, 1 mL atropine, 2 mL diazepam, and
5 mL 0.85 % sodium chloride via intraperitoneal injection
(0.5 mL/100 g). After anesthesia, the modified Allen’s
weight drop method was used to induce spinal cord injury
at the T8 segment in the TERT siRNA and SCI only groups
under aseptic conditions [11]. After modeling, the bleeding
was stopped and the incision sutured, and the bladder was
manually squeezed every 8 h to help urination until spon-
taneous voiding. In the sham group, the spinal cord was
exposed but not damaged. On the basis of GenBank bio-
informatics analysis, we designed sense and antisense
nucleotides targeting astrocyte TERT mRNA in rats
(antisense oligodeoxynucleotide 50-GTTAGGGTTAG-3,
sense oligodeoxynucleotide 50-CTAACCCTAAC-30. In
this study, we used PBCA-NPs-TERT to effectively inhibit
TERT expression. In the TERT siRNA group, PBCA-NPs-
TERT saline solution (91.861692 pmol/lL) was injected at
a dose of 50 lg/kg body mass into the surgical site at
30 min after modeling, twice per day. No administration
was performed in the SCI only groups and sham groups.
Sample Collection
In each group, five rats were sacrificed under anesthesia at
days 1, 3, 5, 7, 14, 28, 42, and 56. Under sterile conditions,
50 mg of spinal cord tissue, 5 mm in length, was taken
from the central zone of the injured spinal cord, and was
then rinsed with 0.1 % DEPC water and stored in nuclease-
free cryovials at -80 C.
Pathological Observation of Spinal Cord Glial Scar
Hematoxylin-Eosin Staining
Two sections from rats were taken at each time point for
hematoxylin-eosin staining to observe the morphology of
spinal cord tissues, changes in glia and nerve cells, and
glial scar hyperplasia.
Immunofluorescence Detection of GFAP and NF-200
Expression
Frozen sections were rinsed with 39 PBS (once for
10 min), blocked with 10 % goat serum for 1 h at room
temperature, and incubated at 4 C overnight. Sections
were rinsed with 39 PBS (once for 10 min), and incubated
in the following primary antibodies: chicken anti-GFAP/
NF-200 polyclonal antibody (1:2,000), mouse anti-CDllb/c
monoclonal antibody (1:200), and rabbit anti-Fibronectin
polyclonal antibody (1:200), for 24 h at 4 C. Sections
were then rinsed with 39 PBS (pH 7.4; once for 5 min),
followed by incubation with secondary antibodies (Dy-
Light488 green fluorescence-labeled goat anti-mouse IgG;
Texas Red-labeled rabbit anti-chicken IgY) for 1 h in the
dark at 37 C. After 39 PBS rinses (once for 5 min), the
sections were observed under a 2009 fluorescence micro-
scope. Numbers of GFAP and NF-200-positive cells in five
fields of view were counted and the area of positive cells
was calculated using Image-ProPlus 6.0 software (Media
Cybernetics Inc., Rockville, MD, USA).
Western Blotting Assay for Detection of TERT
and GFAP Expression
Total protein extract from approximately 50 mg of spinal
cord scar tissue was prepared from the various time points.
Protein samples (20 lL) from each group were resolved
in a 7.5 % sodium dodecyl sulfate polyacrylamide gel
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electrophoresis (SDS-PAGE) gel and transferred onto film.
The samples were incubated in rabbit anti-rat TERT
monoclonal antibody (1:100) for 2 h at 37 C, and then
stored at 4 C overnight. After incubation with horseradish
peroxidase-labeled goat anti-rabbit IgG (1:50) for 1 h at
room temperature, the samples were colored with chro-
mogenic substrate for 2 min in the dark. Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) served as the internal
control, and a gel imaging analysis system was employed
for semi-quantitative analysis. The ratio of telomerase to
GAPDH was calculated.
Detection of TERT and GFAP mRNA by RT-PCR
Total RNA was extracted using the Trizol method
according to the manufacturer’s instructions (Invitrogen).
Primers sequences used were: TERT: upstream, 50-TC
CGCACGTT GGTTGCCCAG-30, downstream, 50-CCTC
TCACCGCGCTCGCA AA-30 (product size = 203 bp);
GADPH: upstream, 50-GCTCTCTGCTCCTCCCTGTT
CT-30, downstream, 50-CAGGCGTCCG ATACGGCCAA
A-30 (product size = 450 bp); GFAP: upstream, 50-CTG A
ATTC TGCTGGCTTCAAGG-30, downstream, 50-CTAA
GCTTGCTCTGCGTTGCGG-30 (product size = 624 bp);
and b-actin: upstream, 50-GCGGGAAATCGTGCTGA CA
TT-30, downstream, 50-GATGGAGTTGA AGGTAGT
TTCGTG-30 (product size = 314 bp). PCR was performed
as follows: denaturing at 94 C for 30 s, annealing at 55 C
for 30 s, extension at 72 C for 30 s, for 35 cycles, fol-
lowed by extension at 72 C for 5 min. PCR products were
analyzed on a 15 g/L agarose gel. TERT and GFAP mRNA
expressions were confirmed by comparing the PCR band
intensity between TERT and GAPDH as well as between
GFAP and b-actin. All gene expression data were calcu-
lated as 2-44Ct.
Statistical Analysis
Data are expressed as mean ± SD, and were analyzed
using SPSS 19.0 (IBM, Armonk, NY, USA). Analysis of
variance for a completely randomized design was used to
compare differences between the three groups. A least
significant difference test was used for comparison between
groups. P \ 0.05 was considered statistically significant.
Results
Quantitative Analysis of Experimental Animals
Four rats died during the modeling and six died after
modeling, which were supplemented with new rats. No
infection occurred after modeling. A total of 120 rats were
included in the final analysis.
Transfection Efficiency of the Plasmid Vector
Negative and false-positive tests showed that the inhibition
rate of the constructed plasmid vector was 81.05 ± 7.65 %.
Results for the Hematoxylin–Eosin Staining
In the SCI only group, there were few hemorrhagic foci in
the spinal cord gray matter and white matter, severe
damage to the structure of the spinal cord, dissolved gray
matter neurons, a large necrotic area, and cyst formation. A
great amount of axons and vacuoles could be seen in the
white matter, and nerve fibers were disordered. By the end
of day 28, the hemorrhagic foci had practically disappeared
in the spinal cord gray matter and white matter, and the
structure of the spinal cord was damaged to a severe extent.
There was further death of gray matter neurons, which
formed a large number of vacuoles. In addition, inflam-
matory infiltration was alleviated, and a large number of
glial cells surrounded the cavity to form a dense glial scar.
In the TERT siRNA group, the spinal cord also appeared to
have visible structural damage, inflammatory cell infiltra-
tion, neuronal loss and disintegration, glial cell hypertro-
phy and hyperplasia, cyst formation and other phenomena,
all of which were milder than those in the SCI only group.
There was no bleeding, cysts or glial scars in the sham
group (Fig. 1).
GFAP and NF-200 Immunofluorescence
Image-ProPlus 6.0 software was used to quantify immu-
nofluorescence images. The GFAP expression at each time
point was significantly higher in the SCI only group (87 %)
than in the TERT siRNA group (67 %) and sham group
(2 %). At 28 days after injury, scar formation stabilized in
the TERT siRNA and SCI only groups, while there was no
scar formation in the sham group. NF-200 expression was
gradually reduced and remained stable until day 28 in the
SCI only group. There were no NF-200-labeled cells in the
spinal cord glial scar and cavity at day 56 after spinal cord
injury. NF-200 expression at each time was significantly
lower in the SCI only group than the TERT siRNA group,
while there was no change in the sham group (Fig. 2).
TERT and GFAP Expression by Western Blotting
Assay
Telomerase reverse transcriptase and GFAP expressions
in the SCI only group were significantly higher than that
in the TERT siRNA (P \ 0.01; v2 = 67.722–96.521,
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P \ 0.05) and sham (v2 = 159.017–167.773, P \ 0.01;
v2 = 68.526–95.461, P \ 0.05) groups at the different time
points. At 28 days after spinal cord injury, TERT and GFAP
expression in the SCI only group reached a peak of
1.217 ± 0.072 and 19.40 ± 0.55, respectively. The TERT
siRNA group showed a higher GFAP expression than the
sham group (v2 = 88.312–121.593, P \ 0.05). There was
no change in GFAP expression in the sham group (Table 1).
mRNA Expression of TERT and GFAP Detected
by Reverse Transcription-PCR
In the SCI only group, TERT and GFAP mRNA were
expressed at 1 day after injury, peaked at 28 days, and then
gradually decreased and remained stable at 56 days. The
mRNA expression of TERT and GFAP was markedly
higher in the SCI only group than the TERT siRNA and
sham groups (P \ 0.05). There were no obvious changes in
TERT and GFAP mRNA expression in the TERT siRNA
and sham groups (Table 2).
Correlation between TERT and Glial Scar Formation
In the SCI only group, GFAP and TERT were positively
expressed at 1 day after injury, peaked at 28 days, and then
gradually decreased and remained stable at 56 days.
Western blotting showed that TERT and GFAP protein
expression showed a linear relationship in the SCI only
group (r = 0.765, P \ 0.01; Fig. 3a), which is consistent
with the results of RT-PCR (r = 0.722, P \ 0.01; Fig. 3b).
However, there was no obvious linear relationship in the
sham group (Western blotting: r = 0.208, P = 0.121; RT-
PCR: r = 0.206, P = 0.180; Fig. 4).
Fig. 1 Astrocytes proliferation and glial scars formation (arrows) at
28 days after spinal cord injury in the telomerase reverse transcriptase
(TERT siRNA) group and SCI only group. The responses of the
TERT siRNA group were greater than in the SCI only group. No
astrocyte proliferation or glial scar formation were seen in the sham
group (9200)
Fig. 2 Expression of GFAP and neurofilament protein 200 (NF-200)
at 28 days after spinal cord injury detected by immunofluorescence
(9100). Panels 1–3: GFAP-positive cells (arrows) in the non-
telomerase reverse transcriptase (SCI only), TERT siRNA, and sham
groups. Panels 4–6: NF-200 positive cells (arrows) in the SCI only,
TERT siRNA, and sham group
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Discussion
After spinal cord injury, the activation of astrocytes in the
injury zone and local microenvironment changes lead to
the formation of glial scars, which can inhibit the growth of
axons [12]. In recent years, the use of transplantation
methods have markedly progressed the treatment of spinal
cord injury, although restoration of spinal cord function
remains to be achieved. The main reason for this is that
current treatments fail to absolutely inhibit glial scar for-
mation after spinal cord injury. In addition, the causes of
glial scar formation are not fully understood.
Glial scar formation after spinal cord injury is a complex
pathophysiological process that involves tissue edema,
inflammation, local ischemia, glutamate receptor hyper-
activation, lipid peroxidation, calcium overload, free radi-
cal damage, astrocyte activation, and apoptosis [13]. In the
SCI only group, there were few hemorrhagic foci in the
spinal cord gray and white matter, severe damage to the
structure of the spinal cord, dissolved gray matter neurons,
a large necrotic area, and cyst formation. A great amount of
axons and vacuoles could be seen in the white matter, and
nerve fibers were disordered. Hemorrhagic foci practically
disappeared in the spinal cord gray matter and white matter
by day 28 after injury, and the structure of the spinal cord
was damaged to a severe extent. There was further death of
gray matter neurons, which formed a large number of
vacuoles. In addition, inflammatory infiltration was alle-
viated, and a large number of glial cells surrounded the
cavity to form a dense glial scar.
Table 1 TERT and GFAP protein expression in the three groups at different times
Time (days) TERT GFAP
SCI only (n = 5) TERT siRNA (n = 5) Sham (n = 5) SCI only (n = 5) TERT siRNA (n = 5) Sham (n = 5)
1 0.274 ± 0.005b 0.081 ± 0.007b 0.072 ± 0.007c 1.98 ± 0.15a 1.10 ± 0.13b 0.46 ± 0.05c
3 0.386 ± 0.004a 0.092 ± 0.004b 0.073 ± 0.006c 6.08 ± 0.23a 3.40 ± 0.45b 0.48 ± 0.04c
5 0.435 ± 0.005a 0.028 ± 0.007b 0.072 ± 0.008c 9.04 ± 0.35a 7.05 ± 0.52b 0.46 ± 0.05c
7 0.557 ± 0.006a 0.091 ± 0.009b 0.074 ± 0.005c 12.30 ± 0.45a 9.62 ± 0.71b 0.46 ± 0.05c
14 0.757 ± 0.021a 0.042 ± 0.004b 0.075 ± 0.004c 17.50 ± 0.50a 14.47 ± 0.37b 0.46 ± 0.05c
28 1.217 ± 0.072a 0.065 ± 0.007ab 0.074 ± 0.005c 19.40 ± 0.55a 16.64 ± 1.02b 0.46 ± 0.05c
42 0.660 ± 0.011a 0.078 ± 0.008b 0.073 ± 0.006c 16.60 ± 1.14a 13.54 ± 0.52b 0.44 ± 0.05c
56 0.180 ± 0.004a 0.083 ± 0.004eb 0.074 ± 0.006c 12.60 ± 1.14a 8.826 ± 0.43b 0.48 ± 0.040c
Data are expressed as mean ± SD
TERT telomerase reverse transcriptase, GFAP glial fibrillary acidic protein
a P \ 0.05, comparison between TERT siRNA and sham group
b P \ 0.05, comparison between TERT siRNA and SCI only group
c P \ 0.05, comparison between SCI only and sham group
Table 2 TERT and GFAP mRNA expression in the three groups at different times
Time (days) TERT mRNA GFAP mRNA
SCI only (n = 5) TERT siRNA (n = 5) Sham (n = 5) SCI only (n = 5) TERT siRNA (n = 5) Sham (n = 5)
1 3.43 ± 0.95a 1.91 ± 0.83b 1.05 ± 0.33c 3.20 ± 0.84a 2.10 ± 0.63b 1.03 ± 0.30c
3 3.90 ± 0.57a 1.94 ± 0.81b 1.07 ± 0.39c 4.17 ± 0.57a 2.40 ± 0.85b 1.04 ± 0.33c
5 5.68 ± 0.90a 2.11 ± 0.93b 1.11 ± 0.55c 5.95 ± 0.66a 4.05 ± 0.79b 1.05 ± 0.40c
7 7.46 ± 0.78a 2.19 ± 0.99b 1.11 ± 0.62c 7.51 ± 0.67a 5.26 ± 0.82b 1.06 ± 0.42c
14 9.23 ± 0.78a 2.40 ± 0.94b 1.12 ± 0.62c 9.30 ± 1.11a 6.63 ± 0.78b 1.07 ± 0.49c
28 13.34 ± 0.87a 2.56 ± 0.71b 1.16 ± 0.69c 13.69 ± 1.0a 10.69 ± 1.1b 1.04 ± 0.28c
42 9.42 ± 0.86a 2.30 ± 0.82b 1.10 ± 0.52c 9.51 ± 0.98a 6.72 ± 0.92b 1.03 ± 0.25c
56 4.48 ± 1.08a 2.20 ± 0.74b 1.04 ± 0.32c 6.20 ± 1.27a 2.36 ± 0.84b 1.04 ± 0.30c
Data are expressed as mean ± SD
TERT telomerase reverse transcriptase, GFAP glial fibrillary acidic protein
a P \ 0.05, comparison between TERT siRNA and sham group
b P \ 0.05, comparison between TERT siRNA and SCI only group
c P \ 0.05, comparison between SCI only and sham group
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Telomerase reverse transcriptase is a critical catalytic
subunit of the telomerase enzyme complex and regulates
telomerase activity, including cell growth and survival [14,
15]. TERT is involved in the activation of telomerase and
prolongs cell life by protecting the telomere. In addition,
TERT has multiple non-telomere length-dependent effects
that are closely associated with cell activation, prolifera-
tion, and apoptosis [6, 9, 16], such as the regulation of
intracellular Ca2? distribution, mitochondrial function,
energy metabolism, growth factor secretion, and apoptotic
gene expression [17–21]. Herein, we focus on the biolog-
ical effects of TERT through which TERT regulates glial
scar formation after spinal cord injury. Previous studies
have shown that glial scar formation after spinal cord
injury is mainly mediated by astrocyte activation. GFAP,
the most important cytokine secreted by activated astro-
cytes, promotes scar formation and inhibits axonal regen-
eration. In the present study, GFAP expression was
gradually reduced in the SCI only group at day 28 after
spinal cord injury and remained stable until day 56, while
TERT expression was normal. Western blotting and RT-
PCR showed that TERT and GFAP protein expressions had
a linear relationship in the SCI only group (r = 0.765,
P \ 0.01; r = 0.722, P \ 0.01, respectively), while there
was no obvious linear relationship in the sham group
(r = 0.208, P = 0.121; r = 0.206, P = 0.180, respec-
tively). These findings suggest that TERT mRNA was
involved in the activation during the formation of glial
scars in the injured spinal cord. It was found that the pro-
cess of astrocyte activation mainly appears as changes in
Ca2? concentrations [22], while TERT is important for the
regulation of Ca2? distribution and transmembrane trans-
port [19, 23]. Therefore, we believe that TERT may acti-
vate astrocytes by regulating Ca2? concentration, thus
contributing to the formation and development of the glial
scar. However, the specific pathway and mechanism
require further study.
Current methods to inhibit TERT expression include
antisense technology, RNA interference, and ribozyme
technology [24]. On the basis of previous studies, we
designed an antisense nucleotide targeting astrocyte TERT
mRNA, to suppress TERT mRNA expression. Negative- and
Fig. 3 a Correlation between TERT and GFAP expression in the
glial scar in the SCI only group. Spearman’s rank correlation test
showed a positive correlation between TERT and GFAP protein
expressions (r = 0.765, P \ 0.01). b Correlation between TERT and
GFAP mRNA expression in the glial scar in the SCI only group.
Spearman’s rank correlation test showed a positive correlation
between TERT and GFAP mRNA expression (r = 0.722, P \ 0.01)
Fig. 4 a Correlation between TERT and GFAP expression in the
glial scar in the sham group. Spearman’s rank correlation test showed
no correlation between TERT and GFAP protein expression
(r = 0.208, P = 0.121). b Correlation between TERT and GFAP
mRNA expression in the glial scar in the sham group. Spearman’s
rank correlation test showed no correlation between TERT and GFAP
mRNA expressions (r = 0.206, P = 0.180)
Neurochem Res (2013) 38:1914–1920 1919
123
false-positive tests showed that the inhibition rate of the
constructed plasmid vector was 81.05 ± 7.65 %, based on
which PBCA-NPs-TERT was confirmed to effectively
inhibit TERT expression.
In summary, we demonstrated that TERT exhibited
dynamic expression in the spinal cord glial scar, similar to
GFAP, which is used to measure glial scar severity, but
there were no changes in TERT and GFAP expressions in
the sham group. Unfortunately, inhibition of TERT mRNA
expression failed to significantly reduce the number of glial
scars, indicating that TERT is not the only contributor to
glial scar formation. Further studies are required to
examine other molecules contributing to the formation of
the glial scar in the spinal cord, thereby deepening our
understanding of the etiology of spinal cord injury and
promoting the treatment of spinal cord injury.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
References
1. Lu P, Jones LL, Tuszynski MH (2007) Axon regeneration
through scars and into sites of chronic spinal cord injury. Exp
Neurol 203:8–21
2. Chen Haoxian, Zheng Xinfeng, Sheng Weibin et al (2009)
Transplantation of low-power laser-irradiated olfactory en-
sheathing cells to promote repair of spinal cord injury in rats.
Neural Regen Res 4:171–177
3. Frise´n J, Haegerstrand A, Risling M, Fried K, Johansson CB,
Hammarberg H, Elde R, Ho¨kfelt T, Cullheim S (1995) Spinal
axons in central nervous system scar tissue are closely related to
laminin-immunoreactive astrocytes. Neuroscience 65:293–304
4. EddlestonM Mucke L (1993) Molecular profile of reactive
astrocytes: implications for their role in neurological disease.
Neuroscience 54:15–36
5. Eng LF, Ghirnikar RS (1994) GFAP and astrogliosis. Brain
Pathol 4:229–237
6. Collins K, Mitchell JR (2002) Telomerase in the human organ-
ism. Oncogene 21:564–579
7. de Lange T (2005) Shelterin: the protein complex that shapes and
safeguards human telomeres. Genes Dev 19:2100–2110
8. Blasco MA (2005) Mice with bad ends: mouse models for the
study of telomeres and telomerase in cancer and aging. EMBO J
24:1095–1103
9. Meyerson M, Counter CM, Eaton EN et al (1997) hEST2, the
putative human telomere-se catalytic subunit gene, is up-regu-
lated in tumor cells and during immortalization. Cell 90:785–795
10. Collins K (2000) Mammalian telomeres and telomerase. Curr
Opin Cell Biol 12:378–383
11. Choi J, Southworth LK, Sarin KY et al (2008) TERT promotes
epithelial proliferation through transcriptional control of a Myc-
and Wnt-related developmental program. PLoS Genet 4:e10
12. Geserick C, Blasco MA (2006) Novel roles for telomerase in
aging. Mech Ageing Dev 127:579–583
13. Takano H, Murasawa S, Asahara T (2008) Functional and gene
expression analysis of hTERT overexpressed endothelial cells.
Biologics 2:547–554
14. Zhang RG, Zhao JJ, Yang LQ, Yang SM, Wang RQ, Chen WS,
Peng GY, Fang DC (2010) RNA interference-mediated hTERT
inhibition enhances TRAIL-induced apoptosis in resistant hepa-
tocellular carcinoma cells. Oncol Rep 23:1013–1019
15. Carlson GD, Gorden C (2002) Current developments in spinal
cord injury research. Spine J 2:116–128
16. Yang MK, Sheng WB (2011) The role of astrocytes in spinal cord
injury repairment. Zhongguo Jizhu Jisui Zazhi 21:947–951
17. Zhou JJ, Wu GC, Hu R et al (2007) Distribution study for glial
scar after experimental spinal cord injury in rats. Zhonghua
Shenjing Waike Zazhi 23:347–350
18. Hajo´s F (2008) Changes in glial fibrillary acidic protein (GFAP)
immunoreactivity reflect neuronal states. Neurochem Res
33:1643–1650
19. Okere CO, Waterhouse BD (2004) Capsaicin increases GFAP
and glutamine synthetase immunoreactivity in rat arcuate nucleus
and median eminence. NeuroReport 15:255–258
20. Naghdi M, Tiraihi T, Mesbah-Namin SA, Arabkheradmand J
(2009) Induction of bone marrow stromal cells into cholinergic-
like cells by nerve growth factor. Iran Biomed J 13:117–123
21. De Lange T (2005) Shelterin: the protein complex that shapes and
safeguards human telomeres. Genes Dev 19:2100–2110
22. Marı´a AB (2005) Mice with bad ends: mouse models for the
study of telomeres and telomerase in cancer and aging. EMBO J
24:1095–1103
23. Fu W, Lee J, Guo Z, Mattson MP (2002) Seizures and tissue
injury induce telomerase in hippocampal microglial cells. Exp
Neurol 178:294–300
24. Reimold I, Domke D, Bender J, Seyfried CA, Radunz HE,
Fricker G (2008) Delivery of nanoparticles to the brain detected
by fluorescence microscopy. Eur J Pharm Biopharm 70:627–632
1920 Neurochem Res (2013) 38:1914–1920
123
